Systematic review and meta-analysis reveals wide variations in sarcopenia prevalence globally due to differing classification criteria, highlighting the need for standardized diagnostic guidelines.
The prevalence of sarcopenia and severe sarcopenia varied considerably according to the classification and cut-off point used. Considering the lack of a single diagnostic for sarcopenia, future studies should adhere to current guidelines, which would facilitate the comparison of results between studies and populations across the globe.
No takes yet. Share an insight, caveat, or question.
Petermann‐Rocha et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: